Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transplantation tolerance induced by mixed chimerism.

T Wekerle1

  • 1Division of Transplantation, Department of Surgery, Vienna General Hospital, University of Vienna, Vienna, Austria. thomas.wekerle@akh-wien.ac.at

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|August 15, 2001
PubMed
Summary

Inducing mixed chimerism offers a promising path to achieve lifelong donor-specific tolerance in organ transplant recipients. Recent advancements in mixed chimerism protocols show potential for safer, clinically applicable tolerance induction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential expression of circulating miRNAs after alemtuzumab induction therapy in lung transplantation.

Scientific reports·2022
Same author

No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients.

Clinical and experimental immunology·2017
Same author

T Cell Subsets Predicting Belatacept-Resistant Rejection: Finding the Root Where the Trouble Starts.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Regulatory T Cells Promote Natural Killer Cell Education in Mixed Chimeras.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Murine models of transplantation tolerance through mixed chimerism: advances and roadblocks.

Clinical and experimental immunology·2017
Same author

Introducing the Wiley Transplant Peer Review Network.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016

Area of Science:

  • Immunology
  • Transplantation Biology
  • Regenerative Medicine

Background:

  • Graft recipients face high morbidity and mortality despite improved transplant outcomes.
  • Lifelong donor-specific tolerance is crucial for enhancing transplant success.
  • Current tolerance induction methods successful in rodents often fail in humans.

Purpose of the Study:

  • To explore mixed chimerism as a viable strategy for clinical tolerance induction in organ transplantation.
  • To review the mechanisms and recent progress in developing mixed chimerism protocols.
  • To address the challenges of host conditioning toxicity in clinical applications.

Main Methods:

  • Review of basic mechanisms of immunologic tolerance induction.
  • Description of mixed chimerism as a tolerance induction strategy.

Related Experiment Videos

  • Analysis of mixed chimerism protocols in rodent, large animal, and non-human primate models.
  • Evaluation of protocols feasible for cadaveric and thoracic transplantation.
  • Assessment of recent advances in reducing host conditioning toxicity.
  • Main Results:

    • Mixed chimerism has demonstrated robust tolerance in various animal models, including non-human primates.
    • Mixed chimerism protocols are being developed for feasibility in cadaveric transplantation.
    • Advances in host conditioning have led to substantially milder protocols.
    • The induction of mixed hematopoietic chimerism is a promising experimental approach.

    Conclusions:

    • Mixed chimerism represents a significant advancement in the pursuit of clinical tolerance for organ transplantation.
    • Milder conditioning protocols are emerging, increasing the clinical feasibility of mixed chimerism.
    • Further development of mixed chimerism protocols could dramatically improve long-term outcomes for transplant recipients.